## CPRT: Copart, Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -5.0% below STRENGTH zone (4.0-10.0%); PEG 2.22 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($37.17)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Groupama Asset Managment Purchases New Stake in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251201T095055 | Neutral | Relevance: 99%
- Groupama Asset Management has acquired a new stake in Copart, Inc. (NASDAQ:CPRT), purchasing 33,521 shares valued at approximately $1.615 million, bringing institutional ownership to 85.78%. Despite beating EPS estimates, Copart's revenue of $1.16 billion missed analyst projections of $1.18 billion. The company holds a "Hold" consensus rating with an average price target of $47.60, and insiders have recently been net sellers of the stock.

**2. Skandinaviska Enskilda Banken AB publ Cuts Stake in Copart, Inc. $CPRT**
- Source: MarketBeat | 20251201T115043 | Neutral | Relevance: 99%
- Skandinaviska Enskilda Banken AB publ reduced its stake in Copart, Inc. by 5.0% in Q2, selling 13,700 shares and retaining 260,652 shares valued at approximately $12.79 million. This move comes amidst significant insider selling from Director Thomas N. Tryforos and CEO Jeffrey Liaw. Despite the institutional interest in Copart, analysts maintain a consensus "Hold" rating with a target price of $47.60, as the stock trades near its 52-week low.

**3. Elevation Point Wealth Partners LLC Sells 11,947 Shares of Copart, Inc. $CPRT**
- Source: MarketBeat | 20251129T125055 | Neutral | Relevance: 99%
- Elevation Point Wealth Partners LLC reduced its stake in Copart, Inc. (NASDAQ:CPRT) by 30.0% in Q2 2025, selling 11,947 shares and retaining 27,903 shares valued at approximately $1.37 million. This comes amid heavy insider selling and mixed analyst ratings, with the stock trading near its 52-week low. Despite an EPS beat, Copart's revenue slightly missed expectations in its recent quarterly report.

**4. Copart, Inc. $CPRT Shares Sold by Hsbc Holdings PLC**
- Source: MarketBeat | 20251130T122106 | Neutral | Relevance: 99%
- HSBC Holdings PLC reduced its stake in Copart, Inc. by 8.5% in the second quarter, although other major institutional investors increased their holdings. Insider selling was also noted, with Director Thomas Tryforos and CEO Jeffrey Liaw selling significant shares. Despite a mixed analyst outlook and stock performance, Copart beat EPS estimates for the quarter.

**5. Copart stock hits 52-week low at $38.66**
- Source: Investing.com | 20251201T093200 | Neutral | Relevance: 99%
- Copart Inc. stock has fallen to a new 52-week low of $38.66, reflecting a 37.15% decrease over the past year and a 39.4% decline from its 52-week high, with the RSI indicating oversold territory. Despite the price drop and a recent revenue miss in Q1 fiscal year 2026 earnings, InvestingPro data highlights Copart's "GREAT" financial health with more cash than debt and a strong Altman Z-Score. Investors are closely monitoring the company's performance amidst market challenges.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-24 | JP Morgan | $45 | $50 | -10% |
| 2025-11-21 | Barclays | $33 | $32 | +3% |
| 2025-11-21 | Baird | $52 | $55 | -5% |
| 2025-11-12 | Barclays | $32 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-24 | JP Morgan | main | Neutral |
| 2025-11-21 | Barclays | main | Underweight |
| 2025-11-21 | Baird | main | Outperform |
| 2025-11-12 | Barclays | init | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($1.19M) |
| Sells | 2 ($10.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 11.3% (+2.4%)
- Blackrock Inc.: 6.5% (-2.4%)
- Principal Financial : 4.2% (+3.2%)
- State Street Corpora: 3.8% (+1.8%)
- JPMORGAN CHASE & CO: 2.7% (+86.7%)

### Key Risks

1. Heavy insider selling: $11M sold (2 transactions in 90 days).
2. Long-term trend broken: trading 21.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.22 elevated, pricing in significant growth expectations. Forward P/E 21.7x stretched relative to 10% growth. Quality metrics strong (ROA 11%, margin 34%). Balance sheet: strong liquidity (7.9x), low leverage (D/E 0.10). Analyst sentiment negative (2 target cuts vs 1 raises). Insider selling cluster ($10.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.9B |
| Beta | 1.12 |
| 52W Range | $38.18 - $63.85 |
| Short Interest | 3.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.22 |
| Forward P/E | 21.7 |
| Current P/E | 23.8 |
| YoY Growth | 9.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -5.0% (minimal 5-day change). Below STRENGTH zone by 9.0pp (needs >4.0% for momentum thesis). AM_20 at -4.0% indicates price below own 20MA trend. Underperforming sector by 3.6pp, stock-specific weakness. Below SMA200 (0.78x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.02% (CS: 11) | Weak |
| RSI_14 | 30.9 | Neutral |
| MACD Histogram | -0.11 | Bearish |
| vs SMA20 | 0.960x | Below |
| vs SMA50 | 0.910x | Below |
| vs SMA200 | 0.781x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.15
- **Stop Loss:** $37.17 (5.1% risk)
- **Target:** $41.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 252
- **Position Value:** $9,865.80
- **Portfolio %:** 9.87%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-19 (Est: $0.39)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.39 | $0.41 | +5.1% |
| 2025Q3 | $0.36 | $0.41 | +13.3% |
| 2025Q2 | $0.42 | $0.42 | +0.8% |
| 2025Q1 | $0.37 | $0.40 | +7.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*